SONOMA PHARMACEUTICALS, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 3-month period ending 2020-06-30, per its 10-Q/A filed 2020-11-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2020-11-17
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2020-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2019-06-30 was 17.00K shares.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2018-06-30 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month |
|---|---|
| 2020-06-30 | 0.00 shares 10-Q/A · filed 2020-11-17 |
| 2019-06-30 | 17.00K shares 10-Q/A · filed 2020-11-17 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |